Elevated circulating sST2 levels have been described by numerous clinical studies as a robust predictor of mortality in patients with heart failure and left ventricular systolic dysfunction.24 High levels of sST2 are then often associated with disease progression due to neutralization of the protective effects of IL-33 in the heart, causing maladaptive remodeling like fibrosis. Here, IL33 is linked to heart failure.